PCSK9 Inhibition: From Current Advances to Evolving Future

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secretory serine protease synthesized primarily by the liver. It mainly promotes the degradation of low-density lipoprotein receptor (LDL-R) by binding LDL-R, reducing low-density lipoprotein cholesterol (LDL-C) clearance. In addition to reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chunping, Chen, Jing, Chen, Huiqi, Zhang, Tong, He, Dongyue, Luo, Qiyuan, Chi, Jiaxin, Hong, Zebin, Liao, Yizhong, Zhang, Shihui, Wu, Qizhe, Cen, Huan, Chen, Guangzhong, Li, Jinxin, Wang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562883/
https://www.ncbi.nlm.nih.gov/pubmed/36230934
http://dx.doi.org/10.3390/cells11192972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562883/
https://www.ncbi.nlm.nih.gov/pubmed/36230934
http://dx.doi.org/10.3390/cells11192972

Ejemplares similares